Neurologic disease activity in people with multiple sclerosis treated with immune checkpoint inhibitors.
Sarah E ConwayDanielle Kei A PuaKathryn B HolroydKristin GalettaShamik BhattacharyyaPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
ICPI use was not associated with increased clinical disease activity in this cohort of older patients with inactive MS.